Furthermore, Seoghyun Lee et al. found that fisetin acted as a good drug candidate for improving the lung function of patients with COPD by suppressing the TNF-α/NF-κB signaling cascade (Lee S. et al., 2018). The gene discussed is NFKB1; the disease is chronic obstructive pulmonary disease.